Cargando…
Early Enhancement of Neuroplasticity Index, the Ratio of Serum Brain-Derived Neurotrophic Factor Level to HAMD-24 Score, in Predicting the Long-Term Antidepressant Efficacy
Background: Current mainstream treatment of major depressive disorder (MDD) has a disadvantage in delayed onset of efficacy, making detection of early signatures predicative of the long-term treatment efficacy urgent. Methods: MDD patients were scored with HAMD-24 and serum brain-derived neurotrophi...
Autores principales: | Zhang, Yuxuan, Cui, Bo, Wang, Tianyu, Lu, Yan, Chen, Zhenlin, Zou, Zhilu, Miao, Jinlin, Zhao, Xiuli, Yuan, Yonggui, Wang, Haosen, Chen, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578865/ https://www.ncbi.nlm.nih.gov/pubmed/34776888 http://dx.doi.org/10.3389/fnbeh.2021.712445 |
Ejemplares similares
-
Translating the BDI and BDI-II into the HAMD and vice versa with equipercentile linking
por: Furukawa, Toshi A., et al.
Publicado: (2019) -
Treatments to post-stroke depression, which is more effective to HAMD improvement? A network meta-analysis
por: Zhang, Jie, et al.
Publicado: (2022) -
Neuroplasticity and the next wave of antidepressant strategies
por: Hayley, Shawn, et al.
Publicado: (2013) -
Effects of Antidepressant Medication on Brain-derived Neurotrophic Factor Concentration and Neuroplasticity in Depression: A Review of Preclinical and Clinical Studies
por: Esalatmanesh, Sophia, et al.
Publicado: (2023) -
Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
por: Levy, Marion J. F., et al.
Publicado: (2018)